Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (unaudited)

v3.10.0.1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
[1]
Current assets    
Cash and cash equivalents $ 6,887 $ 6,939
Short-term investments 4,744
Accounts receivable 23 5
Inventory 46 6
Prepaid expenses and other current assets 1,188 734
Deferred financing fees 59 602
Total current assets 12,947 8,286
Fixed assets, net 871 783
Other long-term assets 88 99
Total assets 13,906 9,168
Current liabilities    
Accounts payable and accrued expenses 2,416 1,733
Other current liabilities 58 250
Total current liabilities 2,474 1,983
Contingent royalty obligation 1,906 1,662
Other non-current liabilities 84
Total liabilities 4,464 3,645
Shareholders' equity    
Common Stock $0.0001 par value; 50,000,000 shares authorized; 15,690,151 and 10,493,233 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively 2 1
Additional paid-in capital 65,251 44,643
Accumulated deficit (55,811) (39,121)
Total shareholders' equity 9,442 5,523
Total liabilities and shareholders' equity 13,906 9,168
Preferred Series A stock [Member]    
Shareholders' equity    
Preferred stock
Preferred Stock [Member]    
Shareholders' equity    
Preferred stock
[1] Derived from audited consolidated financial statements